Showing results (831-840 of 3,716) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|January 9, 2014
Critical role of sorafenib exposure over time for its antitumor activity in thyroid cancerAudrey Bellesoeur, Edith Carton, Olivier Mir, et al.
Investigational New Drugs|February 11, 2015
Preliminary efficacy, safety, pharmacokinetics, pharmacodynamics and quality of life study of pegylated recombinant human arginase 1 in patients with advanced hepatocellular carcinomaThomas Yau, Paul N Cheng, Pierre Chan, et al.
Investigational New Drugs|February 14, 2015
Combretastatin A-4 derived imidazoles show cytotoxic, antivascular, and antimetastatic effects based on cytoskeletal reorganisationKatharina Mahal, Bernhard Biersack, Henrike Caysa, et al.
Investigational New Drugs|April 12, 2015
Sorafenib treatment in Child-Pugh A and B patients with advanced hepatocellular carcinoma: safety, efficacy and prognostic factorsSadahisa Ogasawara, Tetsuhiro Chiba, Yoshihiko Ooka, et al.
Investigational New Drugs|March 27, 2015
Phase I and pharmacokinetics/pharmacodynamics study of the MEK inhibitor RO4987655 in Japanese patients with advanced solid tumorsShinji Nakamichi, Hiroshi Nokihara, Noboru Yamamoto, et al.
Investigational New Drugs|January 1, 1985
Additive cytotoxicity of adriamycin and a naturally occurring growth inhibitor extracted from bovine aortaM Haid, J Cohen, G Mazariegos, et al.
Investigational New Drugs|March 13, 2015
A phase I open-labeled, single-arm, dose-escalation, study of dichloroacetate (DCA) in patients with advanced solid tumorsQuincy Siu-Chung Chu, Randeep Sangha, Jennifer Spratlin, et al.
Investigational New Drugs|July 17, 2012
Tumor regression with a combination of drugs interfering with the tumor metabolism: efficacy of hydroxycitrate, lipoic acid and capsaicinLaurent Schwartz, Adeline Guais, Maurice Israël, et al.
Investigational New Drugs|July 18, 2012
The prostate cancer blocking potential of the histone deacetylase inhibitor LBH589 is not enhanced by the multi receptor tyrosine kinase inhibitor TKI258Stefan Vallo, Jens Mani, Matthias Stastny, et al.
Investigational New Drugs|July 24, 2012
Efficacy of substituted 9-aminoacridine derivatives in small cell lung cancerEtchison Ryan, A Jacobson Blake, A Benoit, et al.
Pageof 372